Immuneering Ownership | Who Owns Immuneering?
Immuneering Ownership Summary
Immuneering is owned by 0.81% institutional investors, 24.00% insiders, and 75.19% retail investors. Citadel advisors is the largest institutional shareholder, holding 6.41% of IMRX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.01% of its assets in Immuneering shares.
IMRX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Immuneering | 0.81% | 24.00% | 75.19% |
| Sector | Healthcare Stocks | 279.19% | 10.62% | -189.81% |
| Industry | Biotech Stocks | 63.96% | 10.74% | 25.30% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Citadel advisors | 1.88M | 6.41% | $2.41M |
| Vanguard group | 1.06M | 3.54% | $2.33M |
| Price t rowe associates inc /md/ | 767.12K | 2.57% | $1.69M |
| Goldman sachs group | 741.55K | 2.52% | $949.18K |
| Blackrock | 533.36K | 1.82% | $682.71K |
| Blackrock funding, inc. /de | 318.76K | 1.07% | $701.28K |
| Two sigma advisers, lp | 248.70K | 0.85% | $318.34K |
| Geode capital management | 208.39K | 0.70% | $458.60K |
| Southport management | 245.00K | 0.69% | $372.40K |
| Northern trust | 158.92K | 0.54% | $203.41K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Southport management | 245.00K | 1.61% | $372.40K |
| Tidemark | 44.40K | 0.04% | $97.68K |
| Bridgeway capital management | 51.35K | 0.00% | $112.97K |
| Two sigma advisers, lp | 248.70K | 0.00% | $318.34K |
| Citadel advisors | 1.88M | 0.00% | $2.41M |
| Td asset management | 150.88K | 0.00% | $331.93K |
| Hightower advisors | 71.36K | 0.00% | $156.99K |
| First manhattan co. llc. | 32.33K | 0.00% | $71.11K |
| Two sigma investments, lp | 50.56K | 0.00% | $111.22K |
| Price t rowe associates inc /md/ | 767.12K | 0.00% | $1.69M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Goldman sachs group | 741.55K | 0.00% | 287.31K |
| Two sigma advisers, lp | 248.70K | 0.00% | 248.70K |
| Susquehanna group, llp | 88.76K | - | 88.76K |
| First manhattan co. llc. | 32.33K | 0.00% | 32.33K |
| Southport management | 245.00K | 1.61% | 30.00K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Cormorant asset management, lp | - | - | -3.30M |
| Blackrock | 533.36K | - | -843.76K |
| Renaissance | - | - | -349.10K |
| Highvista strategies | - | - | -254.51K |
| Prosight management, lp | - | - | -190.00K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Two sigma advisers, lp | 248.70K | 0.00% | 248.70K | $318.34K |
| Jane street group | 20.87K | - | 20.87K | $31.72K |
| Russell investments group | 6.59K | - | 6.59K | $8.44K |
| Macquarie group | 1.14K | - | 1.14K | $1.45K |
| Bnp paribas arbitrage, snc | 349.00 | - | 349.00 | $768.00 |
Sold Out
| Holder | Change |
|---|---|
| Nelson, van denburg & campbell wealth management group | -4.00 |
| Nisa investment advisors | -10.00 |
| Point72 (difc) | -16.00 |
| Farther finance advisors | -80.00 |
| Cubist systematic strategies | -659.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2025 | 3 | -92.86% | 288,934 | -93.28% | - | 0.39% | 2 | -89.47% | 1 | -90.00% |
| Dec 31, 2024 | 23 | -39.47% | 2,290,179 | -47.42% | 7 | 3.60% | 9 | -40.00% | 5 | -70.59% |
| Sep 30, 2024 | 38 | -30.91% | 4,355,311 | -54.58% | 14 | 1.37% | 15 | -58.33% | 17 | - |
| Jun 30, 2024 | 55 | 10.00% | 9,588,469 | -19.23% | 32 | 1.98% | 36 | 80.00% | 17 | -29.17% |
| Mar 31, 2024 | 50 | -3.85% | 11,871,552 | -26.40% | 40 | 1.34% | 20 | -4.76% | 24 | 33.33% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 722.79K | 2.01% | - |
| T. Rowe Price Health Sciences | 431.83K | 1.20% | -6.52K |
| Vanguard Institutional Extnd Mkt Idx Tr | 289.20K | 0.80% | - |
| Fidelity Extended Market Index | 122.69K | 0.34% | 88.64K |
| TD Health Sciences - I | 75.44K | 0.21% | - |
| NT R2000 Index Fund - NL | 60.79K | 0.20% | -260.00 |
| NT R2000 Growth Index Fund - NL | 52.97K | 0.18% | - |
| NT R2000 Index Fund - DC - NL - 2 | 48.11K | 0.16% | -378.00 |
| Range Cancer Therapeutics ETF | 54.84K | 0.15% | - |
| Bridgeway Ultra-Small Company Market | 49.85K | 0.14% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Apr 01, 2024 | Cormorant Asset Management, LP | - | Sell | $919.50 |
| Apr 01, 2024 | Cormorant Asset Management, LP | - | Sell | $305.00 |
| Apr 01, 2024 | Cormorant Asset Management, LP | - | Sell | $1.82K |
| Apr 01, 2024 | Cormorant Asset Management, LP | - | Sell | $30.10 |
| Apr 01, 2024 | Cormorant Asset Management, LP | - | Sell | $307.00 |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q1 | - | - |
| 2024 Q3 | - | - |
| 2024 Q2 | - | 8 |
| 2024 Q1 | 12 | 5 |
| 2023 Q2 | - | - |
IMRX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools